RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Oncovista Innovative Therapies Stock

Oncovista Innovative Therapies P/E 2024

Oncovista Innovative Therapies P/E

-1.7

Ticker

OVIT

ISIN

US68232J1051

WKN

A0NGYY

As of Nov 17, 2024, Oncovista Innovative Therapies's P/E ratio was -1.7, a -5.03% change from the -1.79 P/E ratio recorded in the previous year.

The Oncovista Innovative Therapies P/E history

Oncovista Innovative Therapies Aktienanalyse

What does Oncovista Innovative Therapies do?

Oncovista Innovative Therapies Inc. is an emerging biotechnology company from the USA that specializes in the development of innovative cancer therapies. Founded in 2007, the company is headquartered in Chicago, Illinois. Oncovista Innovative Therapies ist eines der beliebtesten Unternehmen auf Eulerpool.com.

P/E Details

Deciphering Oncovista Innovative Therapies's P/E Ratio

The Price to Earnings (P/E) Ratio of Oncovista Innovative Therapies is a vital metric that investors and analysts use to determine the company’s market value relative to its earnings. It is calculated by dividing the current stock price by the earnings per share (EPS). A higher P/E ratio could suggest that investors are expecting higher future growth, while a lower ratio may indicate a potentially undervalued company or lower growth expectations.

Year-to-Year Comparison

Assessing Oncovista Innovative Therapies's P/E ratio on a yearly basis provides insights into the valuation trends and investor sentiment. An increasing P/E ratio over the years signifies growing investor confidence and expectations for future earnings growth, while a decreasing ratio may reflect concerns over the company's profitability or growth prospects.

Impact on Investments

The P/E ratio of Oncovista Innovative Therapies is a key consideration for investors aiming to balance risk and reward. A comprehensive analysis of this ratio, in conjunction with other financial indicators, aids investors in making informed decisions regarding buying, holding, or selling the company’s stocks.

Interpreting P/E Ratio Fluctuations

Fluctuations in Oncovista Innovative Therapies’s P/E ratio can be attributed to various factors including changes in earnings, stock price movements, and shifts in investor expectations. Understanding the underlying reasons for these fluctuations is essential for predicting future stock performance and assessing the company's intrinsic value.

Frequently Asked Questions about Oncovista Innovative Therapies stock

What is the price-to-earnings ratio of Oncovista Innovative Therapies?

The price-earnings ratio of Oncovista Innovative Therapies is currently -1.7.

How has the price-earnings ratio of Oncovista Innovative Therapies changed compared to last year?

The price-to-earnings ratio of Oncovista Innovative Therapies has increased by -5.03% fallen (meaning "decreased" or "dropped") compared to last year.

What consequences does a high price-earnings ratio have for investors?

A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.

What does a low price-earnings ratio mean?

A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.

Is the price-earnings ratio of Oncovista Innovative Therapies high compared to other companies?

Yes, the price-to-earnings ratio of Oncovista Innovative Therapies is high compared to other companies.

How does an increase in the price-earnings ratio of Oncovista Innovative Therapies affect the company?

An increase in the price-earnings ratio of Oncovista Innovative Therapies would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.

How does a reduction in the price-to-earnings ratio of Oncovista Innovative Therapies affect the company?

A decrease in the price-earnings ratio of Oncovista Innovative Therapies would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.

What are some factors that influence the price-earnings ratio of Oncovista Innovative Therapies?

Some factors that influence the price-earnings ratio of Oncovista Innovative Therapies are the company's growth, financial position, industry development, and the overall economic situation.

How much dividend does Oncovista Innovative Therapies pay?

Over the past 12 months, Oncovista Innovative Therapies paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Oncovista Innovative Therapies is expected to pay a dividend of 0 USD.

What is the dividend yield of Oncovista Innovative Therapies?

The current dividend yield of Oncovista Innovative Therapies is .

When does Oncovista Innovative Therapies pay dividends?

Oncovista Innovative Therapies pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Oncovista Innovative Therapies?

Oncovista Innovative Therapies paid dividends every year for the past 0 years.

What is the dividend of Oncovista Innovative Therapies?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Oncovista Innovative Therapies located?

Oncovista Innovative Therapies is assigned to the 'Health' sector.

Wann musste ich die Aktien von Oncovista Innovative Therapies kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Oncovista Innovative Therapies from 11/17/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 11/17/2024.

When did Oncovista Innovative Therapies pay the last dividend?

The last dividend was paid out on 11/17/2024.

What was the dividend of Oncovista Innovative Therapies in the year 2023?

In the year 2023, Oncovista Innovative Therapies distributed 0 USD as dividends.

In which currency does Oncovista Innovative Therapies pay out the dividend?

The dividends of Oncovista Innovative Therapies are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Oncovista Innovative Therapies

Our stock analysis for Oncovista Innovative Therapies Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Oncovista Innovative Therapies Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.